Related Experiment Video
Updated: Jul 20, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Microvascular function and inflammatory activation in Takotsubo cardiomyopathy.
Ole Geir Solberg1, Lars Aaberge1, Gerhard Bosse2
1Department of Cardiology, Oslo University Hospital, Oslo, Norway.
This study investigated microvascular function and inflammation in Takotsubo syndrome (TTS). While median microvascular resistance was only slightly elevated, about one-third of patients showed dysfunction, with elevated inflammatory markers suggesting immune activation.
Area of Science:
- Cardiology
- Immunology
- Pathophysiology
Background:
- Takotsubo syndrome (TTS) is an acute cardiac condition with unclear pathophysiology.
- Microvascular dysfunction and inflammation are suspected contributors to TTS.
Purpose of the Study:
- To assess microvascular function in the acute phase of TTS.
- To identify inflammatory mediators associated with TTS-induced pathology.
Main Methods:
- Evaluated 20 female TTS patients using cardiac catheterization to measure index of microvascular resistance (IMR) and collected blood samples from aorta and coronary sinus.
- Performed cardiac magnetic resonance imaging (MRI) in the acute phase.
- Compared inflammatory biomarkers with healthy controls and analyzed changes over 3 months.
Main Results:
- Median IMR was slightly elevated (16.5 mmHg·s), but 35% of patients exhibited IMR > 25 mmHg·s, indicating microvascular dysfunction.
- Cardiac MRI showed apical left ventricular involvement in 65% of patients, with a median ejection fraction of 41%.
- Elevated markers of fibrosis, inflammation, and immune activation were observed compared to controls; only IL-1 receptor antagonist and sTIM-3 were higher in the coronary sinus than aorta. Matrix metalloproteinase-9 increased during follow-up.
Conclusions:
- While median IMR was only slightly elevated, a significant proportion of TTS patients display microvascular dysfunction.
- The study supports the involvement of inflammatory pathways, including monocyte/macrophage activation, in TTS.
- Soluble T-cell immunoglobulin mucin domain-3 (sTIM-3) is identified as a potential novel biomarker for TTS.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies